Sutro Biopharma (STRO) EBT Margin Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) EBT Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -30,899.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,899.00 |
| Sep 30, 2025 | -50,908.00 |
| Jun 30, 2025 | 6,562.00 |
| Mar 31, 2025 | 27,455.00 |
| Dec 31, 2024 | -11,543.00 |
| Sep 30, 2024 | -20,979.00 |
| Jun 30, 2024 | -16,483.00 |
| Mar 31, 2024 | -31,334.00 |
| Dec 31, 2023 | 35,277.00 |
| Sep 30, 2023 | -305.00 |
| Jun 30, 2023 | -16,802.00 |
| Mar 31, 2023 | -11,781.00 |
| Dec 31, 2022 | -24,666.00 |
| Sep 30, 2022 | 2,768.00 |
| Jun 30, 2022 | 5,905.00 |
| Mar 31, 2022 | -49,808.00 |
| Dec 31, 2021 | -35,002.00 |
| Sep 30, 2021 | -13,072.00 |
| Jun 30, 2021 | 18,040.00 |
| Mar 31, 2021 | 7,406.00 |